Skip to main content
INTCO MEDICAL TECHNOLOGY CO., LTD. logo

INTCO MEDICAL TECHNOLOGY CO., LTD. — Investor Relations & Filings

Ticker · 300677 ISIN · CNE100003456 LEI · 549300U6H4L6SSU31U28 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,902 across all filing types
Latest filing 2025-08-08 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300677

About INTCO MEDICAL TECHNOLOGY CO., LTD.

https://www.intcomedical.com.cn

INTCO Medical Technology Co., Ltd. is a high-tech manufacturer specializing in the research, development, production, and marketing of medical consumables and durable medical equipment. The company's primary product portfolio includes a wide range of disposable medical gloves, such as nitrile, vinyl, and latex varieties, which serve as critical protective gear in healthcare and industrial settings. Beyond consumables, the firm produces durable medical equipment including manual and electric wheelchairs, hospital beds, and patient mobility aids. It also offers physical therapy products like cold and hot packs and various medical electrodes. With a focus on large-scale production and advanced manufacturing technology, the company serves a global clientele across healthcare, laboratory, and food service sectors. Its operations emphasize quality control and compliance with international standards to ensure product safety and reliability.

Recent filings

Filing Released Lang Actions
关于英科转债即将到期暨赎回的第七次提示性公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement from Yingke Medical Technology Co., Ltd. regarding the upcoming maturity and redemption of its convertible bonds (ticker 123029). It details the bond maturity date, redemption price, last trading day, conversion period, and the forced redemption and delisting of the bonds after maturity. The document is a notification to bondholders about the bond's status and redemption process, not a financial report or detailed financial statement. It is relatively short (1808 characters) and serves as a regulatory announcement about bond maturity and redemption. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other specific categories.
2025-08-08 Chinese
关于英科转债即将到期暨赎回的第六次提示性公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement regarding the upcoming maturity and redemption of a convertible bond issued by the company. It includes details such as bond code, maturity date, redemption price, last trading day, conversion period, and the process for forced redemption and delisting of the bond from the exchange. The document is relatively short (1853 characters) and serves as a notification to bondholders about the bond's maturity and related procedures. It does not contain financial statements, audit information, or detailed financial analysis. It is not a full report but an official announcement about the bond's status and redemption. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as bond redemptions.
2025-08-04 Chinese
关于为子公司提供担保事项的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the progress of providing guarantees for a subsidiary by the parent company. It details the guarantee amount, the parties involved, financial data of the subsidiary, and the terms of the guarantee agreement. There is no indication that this is a full financial report, audit report, or earnings release. The document is a formal announcement about a financing-related guarantee matter, which fits best under Capital/Financing Update (CAP). The document length is 3169 characters, which is relatively short but contains substantive information about the guarantee progress, not just a notice of report publication or a regulatory filing. Therefore, the classification is CAP with high confidence.
2025-08-01 Chinese
关于回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement from Yingke Medical Technology Co., Ltd. regarding the progress of its share repurchase program. It details the number of shares repurchased, the price range, total amount spent, compliance with regulatory rules, and the timeline of the repurchase plan. The document does not contain financial statements or detailed financial analysis but focuses on the update of the company's share buyback activity. The document length is relatively short (1559 characters) and is clearly an update on the repurchase progress rather than a full financial report or earnings release. Therefore, it fits the category of Transaction in Own Shares (POS), which covers reports of the company buying back its own shares.
2025-08-01 Chinese
关于选举产生第四届董事会职工代表董事的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the election of employee representative directors to the company's fourth board of directors. It details the election process, the individuals elected, their qualifications, and the composition of the board after their appointment. There is no financial data, no mention of financial results, no audit information, no regulatory filings beyond the announcement itself, and no reference to any report publication. The content focuses solely on board/management changes, specifically the election of new board members. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and it is not a report publication announcement or a certification, so it is not RPA or RNS.
2025-07-28 Chinese
高朋（上海）律师事务所关于英科医疗股份有限公司2025年第五次临时股东大会的法律意见书
Regulatory Filings
2025-07-25 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.